Clinical Trials Directory

Trials / Completed

CompletedNCT05211063

Effects of CROCUVIS+® on Computer Vision Syndrome, Sleep and Mood Disorders

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
University of Alicante · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

Previous research has shown the efficacy of CROCUVIS+® dietary supplement, based on saffron extract, in the proper functioning of visual health, for example, against the development of glaucoma. The main objective of this study is to evaluate the efficacy of CROCUVIS® in computer vision syndrome, sleep and mood disorders in a sample of university students who use digital devices.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTSaffron extract (Crocus sativus)Daily intake of one tablet for 42 days.
DIETARY_SUPPLEMENTPlaceboDaily intake of one tablet for 42 days.

Timeline

Start date
2022-10-21
Primary completion
2022-12-27
Completion
2023-05-05
First posted
2022-01-27
Last updated
2023-05-11

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT05211063. Inclusion in this directory is not an endorsement.

Effects of CROCUVIS+® on Computer Vision Syndrome, Sleep and Mood Disorders (NCT05211063) · Clinical Trials Directory